The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Intellia downgraded to market perform at Morgan Stanley on concerns for ATTR-CM candidate nexiguran ziclumeran. Read more ...

Havas Health Network has rebranded a U.K. agency. Havas Life Medicom is now Havas Life London, a group focused on brand, ...

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

The Inteleos Foundation, an international nonprofit organization driving access to medical imaging, has announced the addition of two esteemed members to the Board of Directors for 2025, further ...

Leerink Partners analyst Mani Foroohar has maintained their bearish stance on MRNA stock, giving a Sell rating yesterday.Invest with ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Previously, Matt served as Director of Corporate Affairs at Pfizer Rare Disease, where he advanced communications, patient advocacy, and policy initiatives. Before transitioning to healthcare ...

Three recent big-ticket M&A deals have raised expectations the global biotech sector is recovering from its two-year slump.